Johnson and Johnson continues to outperform Novartis by 2.9% in the past three months

Media coverage

• Title	Johnson and Johnson continues to outperform Novartis by 2.9% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	13/05/25
  Persons	Donald Scott

• Title	Johnson and Johnson continues to outperform Roche by 7.5% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	13/05/25
  Persons	Donald Scott

• Title	Johnson and Johnson continues to underperform AstraZeneca by 25.1% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	13/05/25
  Persons	Donald Scott

• Title	Johnson and Johnson continues to outperform Bristol Myers Squibb by 13.0% in the past three months
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	13/05/25
  Persons	Donald Scott

• Title	Johnson and Johnson- 5 Reasons Investors Remain Bearish (and 4 Reasons Why Bullish)
  Media name/outlet	Global Round Up - Sectors
  Country/Territory	United Kingdom
  Date	13/05/25
  Persons	Donald Scott